By allowing ads to appear on this site, you support the local businesses who, in turn, support great journalism.
Placeholder Image Placeholder Image
$1,000 pill now hepatitis C treatment of choice
WASHINGTON (AP) — A $1,000-per-pill drug that insurers are reluctant to pay for has quickly become the treatment of choice for a liver-wasting viral disease that affects more than 3 million Americans. In less than six months, prescriptions for Sovaldi have eclipsed all other hepatitis C pills combined, according to new data from IMS Health. The prospect of a real cure, with fewer nasty side effects, is enticing thousands of patients to get treated for the first time.